Skip to main content

Table 1 Overall number of Aspergillus species isolated according to clinical settings and samples

From: Hospital distribution, seasonality, time trends and antifungal susceptibility profiles of all Aspergillus species isolated from clinical samples from 2015 to 2022 in a tertiary care hospital

Clinical setting

N° of Isolates (%)

A. fumigatus

A. niger

A. flavus

A. terreus

Othersa

Overall

Internal Medicine

169 (50.7%)

58 (17.4%)

58 (17.4%)

36 (10.8%)

12 (3.6%)

333

Surgery

35 (39.8%)

25 (28.4%)

16 (18.2%)

4 (4%)

8 (9%)

88

Intensive care

123 (38.2%)

66 (20.5%)

66 (20.5%)

54 (16.7%)

13 (4%)

322

Outpatient clinic

170 (44.4%)

102 (26.6%)

59 (15.4%)

25 (6.5%)

27 (7%)

383

Sputum

254 (48.7%)

120 (23%)

82 (15.7%)

35 (6.7%)

30 (5.7%)

521

BAL

186 (41.5%)

87 (19.4%)

80 (17.9%)

76 (16.9%)

19 (4.2%)

448

Wound/biopsy

29 (50.9%)

14 (24.6%)

7 (12.3%)

5 (8.8%)

2 (3.5%)

57

Ear swab

6 (15.4%)

16 (41%)

14 (35.9%)

1 (2.6%)

2 (5.1%)

39

Nasal swab

10 (23.9%)

13 (30.9%)

12 (28.6%)

2 (4.7%)

5 (11.9%)

42

Sinus discharge

1 (33.3%)

1 (33.3%)

1 (33.3%)

0

0

3

Pleural fluid

10 (71.4%)

0

2 (14.3%)

0

2 (14,3%)

14

CSF

0

0

1 (100%)

0

0

1

Eye swab

1 (100%)

0

0

0

0

1

total

497 (44.1%)

251 (22.3%)

199 (17.7%)

119 (10.6%)

60 (5,3%)

1126

  1. aOthers include: Aspergillus nidulans, Aspergillus candidus, A. sclerotiorum, A. versicolor, A. lentulus, A. glaucus, A. usutus, A. oryzae, A. clavatus, A. ochraceus